| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | Aug 1, 2023 | CNS Pharmaceuticals, Inc. | 10% Owner | Sell | 22.5 | -94,298 | -37.55% | ✗ | $133.1K |
| Aug 16, 2017 | Aug 18, 2017 | Moleculin Biotech, Inc. | 10% Owner | Sell | 22.5 | -100,000 | -3.47% | ✗ | $170.3K |